Notably, 90% of ccRCC cases involve the loss of both alleles of the VHL gene [76], and VHL-deficient ccRCC exhibits a specific dependency on cysteine for glutathione synthesis, making it a therapeutic target. Here, VHL is linked to nonpapillary renal cell carcinoma.